NCT02637687: A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 154 taking part
- Started
- 16 Dec 2015
- Primary completion
- 20 Jul 2024
- Arms
- Phase 1 dose escalation, Phase 1 dose expansion, Phase 2: Patients with tumors bearing NTRK fusions (IFS)_Cohort 1, Phase 2: Other extra-cranial solid tumors_Cohort 2, Phase 2: Primary CNS tumors_Cohort 3, Phase 2: Bone health assessment_sub-cohort
- Results
- None posted
- 16 Dec 2015: Trial started
- 22 Dec 2015: Trial registered